Compare STOK & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | TILE |
|---|---|---|
| Founded | 2014 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2019 | 1994 |
| Metric | STOK | TILE |
|---|---|---|
| Price | $24.97 | $36.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $46.46 | $45.25 |
| AVG Volume (30 Days) | ★ 782.2K | 389.6K |
| Earning Date | 10-29-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 0.33% |
| EPS Growth | ★ 92.73 | 32.43 |
| EPS | N/A | ★ 1.28 |
| Revenue | $184,420,000.00 | ★ $1,386,854,000.00 |
| Revenue This Year | N/A | $6.25 |
| Revenue Next Year | $39.98 | $5.57 |
| P/E Ratio | ★ N/A | $28.60 |
| Revenue Growth | ★ 404.50 | 5.41 |
| 52 Week Low | $20.32 | $24.40 |
| 52 Week High | $40.22 | $40.50 |
| Indicator | STOK | TILE |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 58.69 |
| Support Level | $24.21 | $33.77 |
| Resistance Level | $33.61 | $36.66 |
| Average True Range (ATR) | 1.33 | 0.92 |
| MACD | 0.35 | 0.17 |
| Stochastic Oscillator | 56.19 | 86.63 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).